NFlection Therapeutics   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2014)

Organization Overview

First Clinical Trial
2020
NCT04435665
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NFlection Therapeutics | NFlection Therapeutics, Inc.